SCHEMBL7306558

SCHEMBL7306558

CC1(C)O[C@H]([C@@H](O)CSc2ccc3ccccc3c2)[C@@H]([C@@H](O)CSc2ccc3ccccc3c2)O1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
BACE1 P56817 9/20 0.44
ANPEP P15144 1/20 0.38
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
EPHX1 P07099 1/20 0.35
UGT2B7 P16662 1/20 0.35
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 3/20 0.35
KCNH2 Q12809 2/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305610 0.77 HTR2A (0.47) UGT2B7SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL7306087 0.77 CYP3A4 (0.38) CYP3A4CYP2C9CYP2C19BACE1ANPEP
SCHEMBL20087750 0.71 SLC6A2 (0.46) CYP3A4CYP2C9CYP2C19BACE1ANPEP
SCHEMBL20087747 0.71 SLC6A2 (0.46) CYP3A4CYP2C9CYP2C19BACE1ANPEP
SCHEMBL20088011 0.71 BACE1 (0.58) CYP3A4CYP2C9CYP2C19BACE1ANPEP
SCHEMBL27611903 0.71 BACE1 (0.58) CYP3A4CYP2C9CYP2C19BACE1ANPEP
SCHEMBL5950493 0.71 ANPEP (0.41) CYP3A4CYP2C9CYP2C19ANPEPALDH1A1
SCHEMBL7305088 0.69 BACE1 (0.49) CYP3A4CYP2C9CYP2C19BACE1ANPEP
Ammonia Solution, Strong SCHEMBL7243545 0.69 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19BACE1ANPEP
SCHEMBL5360150 0.67 BACE1 (0.62) CYP3A4CYP2C9CYP2C19BACE1ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed